Johnson & Johnson Net Income 2006-2021 | JNJ

Johnson & Johnson annual/quarterly net income history and growth rate from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Johnson & Johnson net income for the quarter ending September 30, 2021 was $3.667B, a 3.18% increase year-over-year.
  • Johnson & Johnson net income for the twelve months ending September 30, 2021 was $17.880B, a 5.26% increase year-over-year.
  • Johnson & Johnson annual net income for 2020 was $14.714B, a 2.68% decline from 2019.
  • Johnson & Johnson annual net income for 2019 was $15.119B, a 1.16% decline from 2018.
  • Johnson & Johnson annual net income for 2018 was $15.297B, a 1076.69% increase from 2017.
Johnson & Johnson Annual Net Income
(Millions of US $)
2020 $14,714
2019 $15,119
2018 $15,297
2017 $1,300
2016 $16,540
2015 $15,409
2014 $16,323
2013 $13,831
2012 $10,853
2011 $9,672
2010 $13,334
2009 $12,266
2008 $12,949
2007 $10,576
2006 $11,053
2005 $10,060
Johnson & Johnson Quarterly Net Income
(Millions of US $)
2021-09-30 $3,667
2021-06-30 $6,278
2021-03-31 $6,197
2020-12-31 $1,738
2020-09-30 $3,554
2020-06-30 $3,626
2020-03-31 $5,796
2019-12-31 $4,010
2019-09-30 $1,753
2019-06-30 $5,607
2019-03-31 $3,749
2018-12-31 $3,042
2018-09-30 $3,934
2018-06-30 $3,954
2018-03-31 $4,367
2017-12-31 $-10,713
2017-09-30 $3,764
2017-06-30 $3,827
2017-03-31 $4,422
2016-12-31 $3,814
2016-09-30 $4,272
2016-06-30 $3,997
2016-03-31 $4,457
2015-12-31 $3,215
2015-09-30 $3,358
2015-06-30 $4,516
2015-03-31 $4,320
2014-12-31 $2,521
2014-09-30 $4,749
2014-06-30 $4,326
2014-03-31 $4,727
2013-12-31 $3,519
2013-09-30 $2,982
2013-06-30 $3,833
2013-03-31 $3,497
2012-12-31 $2,567
2012-09-30 $2,968
2012-06-30 $1,408
2012-03-31 $3,910
2011-12-31 $218
2011-09-30 $3,202
2011-06-30 $2,776
2011-03-31 $3,476
2010-12-31 $1,942
2010-09-30 $3,417
2010-06-30 $3,449
2010-03-31 $4,526
2009-12-31 $2,206
2009-09-30 $3,345
2009-06-30 $3,208
2009-03-31 $3,507
2008-12-31 $2,714
2008-09-30 $3,310
2008-06-30 $3,327
2008-03-31 $3,598
2007-12-31 $2,374
2007-09-30 $2,548
2007-06-30 $3,081
2007-03-31 $2,573
2006-12-31 $2,168
2006-09-30 $2,760
2006-06-30 $2,820
2006-03-31 $3,305
2005-12-31 $2,095
2005-09-30 $2,538
2005-06-30 $2,588
2005-03-31 $2,839
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $449.095B $93.775B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $299.559B 14.19
AbbVie (ABBV) United States $240.283B 11.05
Eli Lilly (LLY) United States $226.445B 28.08
Novo Nordisk (NVO) Denmark $224.742B 29.73
Merck (MRK) United States $203.541B 13.94
Novartis AG (NVS) Switzerland $190.436B 13.71
GlaxoSmithKline (GSK) United Kingdom $123.159B 15.00